What dosing interval and doses do you use in practice when considering belantamab in elderly patients with relapsed myeloma?
Taking quality of life and ocular toxicity into account.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Harvard Medical School
Answered on
I generally use it every 8-12 weeks at 1.9 mg/m2. I start every 3 weeks and very quickly switch to every 8-12 weeks.
Join for free or sign in to see the full answer